Latest stomach cancer Stories
LOS ANGELES, Nov. 19, 2012 /PRNewswire/ -- Actress and gastric sleeve recipient Jodi Taffel has always had a fun-loving, energetic personality, in spite of struggling with excessive weight for years. Although she was not extremely active prior to her surgery, she longed to fully engage in the many activities and trips she and her boyfriend planned together. However, the extra pounds made it difficult for Taffel to feel comfortable even when walking up a flight of stairs. Last...
ASGE encourages patients and families to learn about the disease and seek support OAK BROOK, Ill., Nov. 15, 2012 /PRNewswire-USNewswire/ -- This November, the American Society for Gastrointestinal Endoscopy (ASGE) is raising awareness about pancreatic cancer and encouraging patients and their families to become educated about the disease, to ask their doctor about treatments and to reach out for support. Pancreatic cancer is the fourth leading cause of cancer deaths in the United...
INDIANAPOLIS, Oct. 15, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the REGARD trial, a Phase III study of ramucirumab (IMC-1121B) in patients with metastatic gastric cancer, met its primary endpoint of improved overall survival and also showed prolonged progression-free survival. This trial is the first Phase III data read-out for ramucirumab. The REGARD trial compared ramucirumab and best supportive care to placebo and best supportive care as a...
Phase III data reported at ESMO 2012 New trial data showing improvements in the treatment of esophageal and gastrointestinal cancers were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. Phase III, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy The first phase III trial to address the need for second-line treatments in esophageal cancer shows that...
People with AIDS are at increased risk for developing esophageal and stomach carcinoma as well as non-Hodgkin lymphomas (NHLs), according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. "People diagnosed with AIDS are living longer due to improved therapies. However, they remain at increased risk of developing a number of different cancers," said E. Christina Persson, PhD, of the National Cancer Institute and lead author of this...
LAUSANNE, Switzerland, September 21, 2012 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today presented the 'JCA-Mauvernay Award' to Doctor Masanobu Oshima from Kanazawa University for his research on 'The Role of Inflammatory Responses in Gastric Cancer Development' and Doctor Shinji Tanaka from the...
Connie K. Ho for redOrbit.com – Your Universe Online New evidence from the American Cancer Society reveals that, even though there is an overall drop in death rates, cancer has become one of the leading causes of death for Hispanics in the U.S. In 2009, a total of 29,935 individuals of Hispanic heritage died of cancer compared to 29,611 deaths from heart disease. In the study, researchers tracked how cancer had surpassed heart disease as the number one disease causing death. In...
BE is a condition that predisposes people to develop one of the world's commonest cancers Genetic variations that are linked with the onset of Barrett's oesophagus (BE), a pre-cancerous condition of the lower end of the gullet, have been identified for the first time. The discovery of variations in regions on two chromosomes makes it possible to develop screening tests for people at high risk of developing the disease. Although it's been thought for some time that there may be genetic...
New research study “Gastric Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020” prepared by GlobalData has been recently published by Market Publishers Ltd. The report finds that the global gastric cancer drug market will experience robust growth over the next decade. London, UK (PRWEB) September 04, 2012 The global gastric cancer drug market will experience robust growth over the next decade, driven by the rapid uptake and market expansion...
LOS ANGELES, Aug. 6, 2012 /PRNewswire/ -- Bariatric surgery is widely considered an extremely safe and effective weight loss method. It's not meant to be the first option you reach for in the tool box, but for many people who have struggled in vain with diet and exercise, it may well be the last option they ever have to turn to. At Dr. Feiz & Associates, a leading weight loss surgery center in Beverly Hills, CA, Dr. Michael Feiz has seen firsthand the dramatic change his...
